Literature DB >> 18046481

Topical applications of iron chelators in photosensitization.

Asta Juzeniene1, Petras Juzenas, Vladimir Iani, Johan Moan.   

Abstract

Generation of the reactive oxygen species (ROS) in skin by exposure to ultraviolet (UV) radiation induces a number of cutaneous pathologies such as skin cancer, photosensitization, and photoaging among others. Skin iron catalyzes UV generation of ROS. Topical application of iron chelators reduces erythema, epidermal and dermal hypertrophy, wrinkle formation, tumour appearance. It has been proposed that iron chelators can be useful agents against damaging effects of both short- and long-term UV exposure. A better understanding of the action mechanisms of iron chelators, might be useful to developing effective anticancer and antiphotoaging cosmetic products. Iron chelators may lead to accumulation of protoporphyrin IX (PpIX), a strong photosensitizer. The action of iron chelators in skin, related to PpIX increase has not yet been thoroughly studied. Therefore, we have investigated the formation of PpIX in normal mouse skin after topical application of creams containing metal chelators. The amount and distribution of porphyrins formed was determined by means of non-invasive fluorescence spectroscopy. Deferoxamine (DF), ethylenediaminetetraacetic acid (EDTA), 1,2-diethyl-3-hydroxypyridin-4-one (CP94), but not meso-2,3-dimercaptosuccinic acid (DMSA), caused increased accumulation of endogenous porphyrins in the skin. Fluorescence excitation and emission spectroscopy confirmed that PpIX was the main fluorescent species. The amount of PpIX accumulated in skin under the present conditions was not large enough to produce any significant erythema after light exposure. Further studies are needed to evaluate the role of PpIX induced by iron chelators used, against photoaging and cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046481     DOI: 10.1039/b703861e

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  7 in total

1.  Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines.

Authors:  Jiabin Yang; Yumin Xia; Xiaoming Liu; Shan Jiang; Layuan Xiong
Journal:  Lasers Med Sci       Date:  2009-08-25       Impact factor: 3.161

2.  Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.

Authors:  Takeshi Hara; Aya Koda; Naoko Nozawa; Urara Ota; Hikaru Kondo; Hitoshi Nakagawa; Atsuko Kamiya; Kazutoshi Miyashita; Hiroshi Itoh; Motowo Nakajima; Tohru Tanaka
Journal:  FEBS Open Bio       Date:  2016-04-29       Impact factor: 2.693

3.  AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.

Authors:  Amy L Bogue; Warunya Panmanee; Cameron T McDaniel; Joel E Mortensen; Edwin Kamau; Luis A Actis; Jay A Johannigman; Michael J Schurr; Latha Satish; Nalinikanth Kotagiri; Daniel J Hassett
Journal:  PLoS One       Date:  2021-03-03       Impact factor: 3.240

Review 4.  The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Authors:  Daniel J Hassett; Rhett A Kovall; Michael J Schurr; Nalinikanth Kotagiri; Harshita Kumari; Latha Satish
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

5.  Deferoxamine to Minimize Fibrosis During Radiation Therapy.

Authors:  Ruth Tevlin; Michael T Longaker; Derrick C Wan
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-07-26       Impact factor: 4.947

6.  AB569, a Novel, Topical Bactericidal Gel Formulation, Kills Pseudomonas aeruginosa and Promotes Wound Healing in a Murine Model of Burn Wound Infection.

Authors:  Amanda Barry; Warunya Panmanee; Daniel J Hassett; Latha Satish
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

7.  Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.

Authors:  Sun Yang; Frank L Meyskens
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.